Legal & General Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Legal & General Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Hold	132,199	–	–	﹤0.01%	1942
2025 Q4	$1.86M	Sell	132,199 -13,926	-10%	-$195K	﹤0.01%	2003
2025 Q3	$2.04M	Hold	146,125	–	–	﹤0.01%	1972
2025 Q2	$2.2M	Hold	146,125	–	–	﹤0.01%	1932
2025 Q1	$1.93M	Hold	146,125	–	–	﹤0.01%	1938
2024 Q4	$2.31M	Sell	146,125 -10,335	-7%	-$155K	﹤0.01%	1919
2024 Q3	$2.49M	Hold	156,460	–	–	﹤0.01%	1880
2024 Q2	$2.38M	Sell	156,460 -7,010	-4%	-$100K	﹤0.01%	1858
2024 Q1	$2.4M	Hold	163,470	–	–	﹤0.01%	1858
2023 Q4	$2.27M	Hold	163,470	–	–	﹤0.01%	1882
2023 Q3	$2.19M	Hold	163,470	–	–	﹤0.01%	1855
2023 Q2	$2.06M	Hold	163,470	–	–	﹤0.01%	1915
2023 Q1	$1.86M	Hold	163,470	–	–	﹤0.01%	1907
2022 Q4	$1.69M	Hold	163,470	–	–	﹤0.01%	1960
2022 Q3	$1.71M	Sell	163,470 -38,415	-19%	-$409K	﹤0.01%	1941
2022 Q2	$2.24M	Hold	201,885	–	–	﹤0.01%	1838
2022 Q1	$2.25M	Hold	201,885	–	–	﹤0.01%	1937
2021 Q4	$2.64M	Buy	201,885 +10,335	+5%	+$130K	﹤0.01%	1894
2021 Q3	$2.5M	Hold	191,550	–	–	﹤0.01%	1917
2021 Q2	$2.82M	Hold	191,550	–	–	﹤0.01%	1824
2021 Q1	$2.35M	Hold	191,550	–	–	﹤0.01%	1904
2020 Q4	$2.73M	Hold	191,550	–	–	﹤0.01%	1759
2020 Q3	$2.67M	Sell	191,550 -4,760	-2%	-$56.7K	﹤0.01%	1644
2020 Q2	$2.08M	Sell	196,310 -2,500	-1%	-$25.4K	﹤0.01%	1721
2020 Q1	$1.61M	Hold	198,810	–	–	﹤0.01%	1671
2019 Q4	$1.61M	Hold	198,810	–	–	﹤0.01%	1896
2019 Q3	$1.51M	Hold	198,810	–	–	﹤0.01%	1840
2019 Q2	$1.49M	Hold	198,810	–	–	﹤0.01%	1820
2019 Q1	$1.61M	Hold	198,810	–	–	﹤0.01%	1784
2018 Q4	$1.5M	Sell	198,810 -11,065	-5%	-$77.8K	﹤0.01%	1724
2018 Q3	$1.45M	Sell	209,875 -80,635	-28%	-$539K	﹤0.01%	1832
2018 Q2	$1.87M	Sell	290,510 -94,670	-25%	-$597K	﹤0.01%	1697
2018 Q1	$2.52M	Sell	385,180 -24,695	-6%	-$173K	﹤0.01%	1499
2017 Q4	$3.08M	Sell	409,875 -117,000	-22%	-$843K	﹤0.01%	1378
2017 Q3	$3.76M	Sell	526,875 -29,500	-5%	-$212K	﹤0.01%	1217
2017 Q2	$4.69M	Sell	556,375 -13,500	-2%	-$110K	﹤0.01%	1014
2017 Q1	$4.58M	Sell	569,875 -40,000	-7%	-$345K	﹤0.01%	977
2016 Q4	$5.53M	Sell	609,875 -42,000	-6%	-$391K	0.01%	857
2016 Q3	$6.05M	Sell	651,875 -155,520	-19%	-$1.48M	0.01%	753
2016 Q2	$8.28M	Sell	807,395 -38,000	-4%	-$348K	0.01%	690
2016 Q1	$7.64M	Hold	845,395	–	–	0.01%	686
2015 Q4	$7.83M	Buy	845,395 +103,520	+14%	+$1.13M	0.01%	688
2015 Q3	$9.48M	Sell	741,875 -3,500	-0.5%	-$43.5K	0.01%	662
2015 Q2	$8.25M	Sell	745,375 -13,000	-2%	-$144K	0.01%	672
2015 Q1	$8.66M	Sell	758,375 -211,500	-22%	-$2.24M	0.01%	668
2014 Q4	$9.79M	Sell	969,875 -69,600	-7%	-$733K	0.01%	663
2014 Q3	$10.9M	Hold	1,039,475	–	–	0.01%	648
2014 Q2	$8.98M	Sell	1,039,475 -139,695	-12%	-$1.17M	0.01%	665
2014 Q1	$10.4M	Buy	1,179,170 +44,000	+4%	+$383K	0.01%	651
2013 Q4	$9.32M	Buy	1,135,170 +62,370	+6%	+$494K	0.01%	639
2013 Q3	$8.12M	Buy	1,072,800 +84,000	+8%	+$611K	0.01%	650
2013 Q2	$7.47M	Buy	+988,800	New	+$7.22M	0.01%	657

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Legal & General Group's RDY Position: Q1 2026 in Review

Legal & General Group held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 132,199 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1942.

Legal & General Group first reported a position in RDY in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.9M in Q3 2014. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Legal & General Group held 132,199 shares of Dr. Reddy's Laboratories worth $1.83M as of Q1 2026.
Legal & General Group left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1942 holding.
Legal & General Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 52 quarters since.
Legal & General Group's Dr. Reddy's Laboratories position peaked at $10.9M in Q3 2014.
247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.